PROTACs to RIPTACs: Arvinas founder snags $76M for next bet, Halda Therapeutics
A leader in the protein degradation space, Yale's Craig Crews, is back with another biotech, Halda Therapeutics. On Tuesday, the startup announced $76 million in funding to take forward a ...
endpoints.news